Speaker: Prof Amit C Nathwani, Katharine Dormandy Haemophilia Centre, UK
Professor Amit C. Nathwani is the Director of the Katharine Dormandy Haemophilia Centre at the Royal Free Hospital. He is also the North London Cancer Network lead for Chronic Lymphocytic Leukaemia. He graduated in Medicine from the University of Aberdeen in 1984. His PhD was on the regulation of the tissue factor gene. In 1997 he moved briefly to St Jude Children’s Research Hospital, Memphis, Tennessee, USA to work with Dr Arthur Nienhuis on adeno-associated virus mediated gene transfer, which is where he started his pioneering work on gene therapy for haemophilia B. In 2001 he returned to University College London as a Senior Lecturer in Haematology and a Consultant to the National Blood Services in the U.K. He was the first to show successful correction of bleeding diathesis in patients with severe haemophilia B using a distinct gene transfer approach developed in collaboration with Drs Davidoff and Nienhuis at St Jude Children’s Research Hospital. Prof Nathwani’s team of clinical and non-clinical scientists and students are currently engaged in a diverse range of translational research including gene therapy for haemophilia A, congenital bleeding disorder, chronic lymphocytic leukaemia, age related macular degeneration and hepatocellular carcinoma. Professor Nathwani is on the advisory boards of various medical charities and biotech companies. He is also a frequent reviewer for a wide range of scientific journals and granting bodies.